242 related articles for article (PubMed ID: 6224417)
1. Juvenile GM2 gangliosidosis (AMB variant): inability to activate hexosaminidase A by activator protein.
Inui K; Grebner EE; Jackson LG; Wenger DA
Am J Hum Genet; 1983 Jul; 35(4):551-64. PubMed ID: 6224417
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of the hexosaminidase A activator protein in a case of GM2 gangliosidosis; variant AB.
Hechtman P; Gordon BA; Ng Ying Kin NM
Pediatr Res; 1982 Mar; 16(3):217-22. PubMed ID: 6801612
[TBL] [Abstract][Full Text] [Related]
3. GM2-ganglioside metabolism in hexosaminidase A deficiency states: determination in situ using labeled GM2 added to fibroblast cultures.
Raghavan SS; Krusell A; Krusell J; Lyerla TA; Kolodny EH
Am J Hum Genet; 1985 Nov; 37(6):1071-82. PubMed ID: 2934978
[TBL] [Abstract][Full Text] [Related]
4. The specificity of human N-acetyl-beta-D-hexosaminidases towards glycosphincolipids is determined by an activator protein.
Conzelmann E; Sandhoff K
Adv Exp Med Biol; 1980; 125():295-306. PubMed ID: 6444774
[TBL] [Abstract][Full Text] [Related]
5. The human GM2 activator protein. A substrate specific cofactor of beta-hexosaminidase A.
Meier EM; Schwarzmann G; Fürst W; Sandhoff K
J Biol Chem; 1991 Jan; 266(3):1879-87. PubMed ID: 1824846
[TBL] [Abstract][Full Text] [Related]
6. Substrate binding properties of the human liver hexosaminidase A activator protein.
Hechtman P; Isaacs C; Smith-Jones L
Can J Biochem Cell Biol; 1985 Aug; 63(8):830-8. PubMed ID: 2933135
[TBL] [Abstract][Full Text] [Related]
7. The protein activator specific for the enzymic hydrolysis of GM2 ganglioside in normal human brain and brains of three types of GM2 gangliosidosis.
Hirabayashi Y; Li YT; Li SC
J Neurochem; 1983 Jan; 40(1):168-75. PubMed ID: 6848657
[TBL] [Abstract][Full Text] [Related]
8. Specificity of mouse GM2 activator protein and beta-N-acetylhexosaminidases A and B. Similarities and differences with their human counterparts in the catabolism of GM2.
Yuziuk JA; Bertoni C; Beccari T; Orlacchio A; Wu YY; Li SC; Li YT
J Biol Chem; 1998 Jan; 273(1):66-72. PubMed ID: 9417048
[TBL] [Abstract][Full Text] [Related]
9. Complexing of glycolipids and their transfer between membranes by the activator protein for degradation of lysosomal ganglioside GM2.
Conzelmann E; Burg J; Stephan G; Sandhoff K
Eur J Biochem; 1982 Apr; 123(2):455-64. PubMed ID: 6210531
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of two variants of type-AB GM2-gangliosidosis using chromogenic substrates.
Li YT; Hirabayashi Y; Li SC
Am J Hum Genet; 1983 May; 35(3):520-2. PubMed ID: 6222647
[TBL] [Abstract][Full Text] [Related]
11. Ganglioside GM2 N-acetyl-beta-D-galactosaminidase activity in cultured fibroblasts of late-infantile and adult GM2 gangliosidosis patients and of healthy probands with low hexosaminidase level.
Conzelmann E; Kytzia HJ; Navon R; Sandhoff K
Am J Hum Genet; 1983 Sep; 35(5):900-13. PubMed ID: 6614006
[TBL] [Abstract][Full Text] [Related]
12. Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses.
Charrow J; Binns HJ
Clin Chim Acta; 1986 Apr; 156(1):41-9. PubMed ID: 2938852
[TBL] [Abstract][Full Text] [Related]
13. Hereditary heat-labile hexosaminidase B: a variant whose homozygotes synthesize a functional HEX A.
Navon R; Kopel R; Nutman J; Frisch A; Conzelmann E; Sandhoff K; Adam A
Am J Hum Genet; 1985 Jan; 37(1):138-46. PubMed ID: 3156493
[TBL] [Abstract][Full Text] [Related]
14. Plasma G
Blondel A; Kraoua I; Marcelino C; Khrouf W; Schlemmer D; Ganne B; Caillaud C; Fernández-Eulate G; Turki IBY; Dauriat B; Bonnefont-Rousselot D; Nadjar Y; Lamari F
Mol Genet Metab; 2023 Feb; 138(2):106983. PubMed ID: 36709536
[TBL] [Abstract][Full Text] [Related]
15. Prenatal diagnosis of GM2 gangliosidosis with high residual hexosaminidase A activity (variant B1; pseudo AB variant).
Conzelmann E; Nehrkorn H; Kytzia HJ; Sandhoff K; Macek M; Lehovský M; Elleder M; Jirásek A; Kobilková J
Pediatr Res; 1985 Nov; 19(11):1220-4. PubMed ID: 2933632
[TBL] [Abstract][Full Text] [Related]
16. [Isolation and characteristics of hexosaminidase A and activator protein from human kidney].
Aronovich EL; Akhunov VS; Krasnopol'skaia KD
Biokhimiia; 1990 Jan; 55(1):43-51. PubMed ID: 2140519
[TBL] [Abstract][Full Text] [Related]
17. Activating proteins for ganglioside GM2 degradation by beta-hexosaminidase isoenzymes in tissue extracts from different species.
Burg J; Banerjee A; Conzelmann E; Sandhoff K
Hoppe Seylers Z Physiol Chem; 1983 Jul; 364(7):821-9. PubMed ID: 6225718
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of 4-methylumbelliferyl-beta-D-N-acetylglucosamine-6-sulfate and its use in classification of GM2 gangliosidosis genotypes.
Bayleran J; Hechtman P; Saray W
Clin Chim Acta; 1984 Nov; 143(2):73-89. PubMed ID: 6239713
[TBL] [Abstract][Full Text] [Related]
19. In cellulo examination of a beta-alpha hybrid construct of beta-hexosaminidase A subunits, reported to interact with the GM2 activator protein and hydrolyze GM2 ganglioside.
Sinici I; Yonekawa S; Tkachyova I; Gray SJ; Samulski RJ; Wakarchuk W; Mark BL; Mahuran DJ
PLoS One; 2013; 8(3):e57908. PubMed ID: 23483939
[TBL] [Abstract][Full Text] [Related]
20. Crystallographic structure of human beta-hexosaminidase A: interpretation of Tay-Sachs mutations and loss of GM2 ganglioside hydrolysis.
Lemieux MJ; Mark BL; Cherney MM; Withers SG; Mahuran DJ; James MN
J Mol Biol; 2006 Jun; 359(4):913-29. PubMed ID: 16698036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
